Sensus Healthcare climbs on collaboration with radiation specialist

Sensus Healthcare

06/02/2024 18:08

** Shares of medical device maker Sensus Healthcare  SRTS.O 
rise 6.5% to $3.45 
    ** Co says it is collaborating with CureRays, an
Atlanta-based radiation oncology specialist
    ** Says CureRays will provide Sensus' dermatology customers
with supervision to assure patient safety, quality, reliability
of outcomes and conformance with regulatory requirements 
    ** CureRays will also research new indications like
inflammatory diseases for Sensus' superficial radiotherapy -
SRTS
    ** Including session's move, stock down 60.3% in the last 12
months

 (Reporting by Christy Santhosh)
 ((Christy.Santhosh@thomsonreuters.com))